1641: Tjoa BA, Murphy GP. Development of dendritic-cell based prostate cancer
vaccine. Immunol Lett. 2000 Sep 15;74(1):87-93. Review. PubMed PMID: 10996633.


1642: Tjoa BA, Murphy GP. Progress in active specific immunotherapy of prostate
cancer. Semin Surg Oncol. 2000 Jan-Feb;18(1):80-7. Review. PubMed PMID: 10617899.


1643: Tjoa BA, Lodge PA, Salgaller ML, Boynton AL, Murphy GP. Dendritic
cell-based immunotherapy for prostate cancer. CA Cancer J Clin. 1999
Mar-Apr;49(2):117-28, 65. PubMed PMID: 11198886.


1644: Tjoa BA, Simmons SJ, Elgamal A, Rogers M, Ragde H, Kenny GM, Troychak MJ,
Boynton AL, Murphy GP. Follow-up evaluation of a phase II prostate cancer vaccine
trial. Prostate. 1999 Jul 1;40(2):125-9. PubMed PMID: 10386473.


1645: Tjoa BA, Erickson SJ, Bowes VA, Ragde H, Kenny GM, Cobb OE, Ireton RC,
Troychak MJ, Boynton AL, Murphy GP. Follow-up evaluation of prostate cancer
patients infused with autologous dendritic cells pulsed with PSMA peptides.
Prostate. 1997 Sep 1;32(4):272-8. PubMed PMID: 9288186.


1646: Tjoa BA, Erickson SJ, Bowes VA, Salgaller ML, Lodge PA, McLean JG, Ragde H,
Kenny GM, Boynton AL, Murphy GP. Cancer immunotherapy for prostate cancer. Can J 
Urol. 1997 Jun;4(2 Supp 1):79-82. PubMed PMID: 12735843.